# EDGAR Filing Document

**Accession Number:** 0001867096
**File Stem:** 0001867096-26-000023
**Filing Date:** 2026-4
**Character Count:** 1134
**Document Hash:** e80b2ddbd6f5e6136b689ec9fa1ddaa1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001867096-26-000023.hdr.sgml**: 20260423

**ACCESSION NUMBER**: 0001867096-26-000023

**CONFORMED SUBMISSION TYPE**: ARS

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260423

**DATE AS OF CHANGE**: 20260423

**EFFECTIVENESS DATE**: 20260423

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Xeris Biopharma Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001867096
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 871082097
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** ARS
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40880
- **FILM NUMBER:** 26889631

**BUSINESS ADDRESS:**
- **STREET 1:** 1375 WEST FULTON STREET, SUITE 1300
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60607
- **BUSINESS PHONE:** 844-445-5704

**MAIL ADDRESS:**
- **STREET 1:** 1375 WEST FULTON STREET, SUITE 1300
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60607

### Attached PDF Documents

**Attachment 1:** `xers2025annualreport.pdf`

_No text found in this document._